{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:07:08Z","timestamp":1766138828385,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.japh.2024.102180","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T11:25:21Z","timestamp":1723289121000},"page":"102180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9122-2882","authenticated-orcid":false,"given":"Shelby","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-0741","authenticated-orcid":false,"given":"Stevie","family":"Veach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eilan","family":"Alhersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-7224","authenticated-orcid":false,"given":"Matthew","family":"Witry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10161","key":"10.1016\/j.japh.2024.102180_bib1","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.japh.2024.102180_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.15585\/mmwr.mm7224a1","article-title":"National, state-level, and county-level prevalence estimates of adults aged \u226518 years self-reporting a lifetime diagnosis of depression\u2014United States, 2020","volume":"72","author":"Lee","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.japh.2024.102180_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.japh.2024.102180_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11606-017-4181-0","article-title":"Screening for behavioral health conditions in primary care settings: a systematic review of the literature","volume":"33","author":"Mulvaney-Day","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"issue":"5","key":"10.1016\/j.japh.2024.102180_bib6","article-title":"Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review","volume":"10","author":"Grochtdreis","year":"2015","journal-title":"PLOoS One"},{"issue":"4","key":"10.1016\/j.japh.2024.102180_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2015.18392","article-title":"Screening for depression in adults: US Preventive Services Task Force recommendation statement","volume":"315","author":"Siu","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.japh.2024.102180_bib8","article-title":"The rate of depression screening at a federally qualified community health center","volume":"2","author":"Maimone","year":"2015","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"9","key":"10.1016\/j.japh.2024.102180_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074610","article-title":"Challenges and implications of routine depression screening for depression in chronic disease and multimorbidity: a cross sectional study","volume":"8","author":"Jani","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.japh.2024.102180_bib10","article-title":"Depression and chronic diseases: it is time for a synergistic mental health and primary care approach","volume":"15","author":"Voinov","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"10.1016\/j.japh.2024.102180_bib11","first-page":"85","article-title":"Pharmacists as accessible health care providers: quantifying the opportunity","volume":"28","author":"Valliant","year":"2022","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"3","key":"10.1016\/j.japh.2024.102180_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.sapharm.2019.05.024","article-title":"Community pharmacy staff interactions with patients who have risk factors or warning signs of suicide","volume":"16","author":"Carpenter","year":"2020","journal-title":"Res. Social Adm. Pharm"},{"author":"Millonig","key":"10.1016\/j.japh.2024.102180_bib13"},{"issue":"1","key":"10.1016\/j.japh.2024.102180_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1331\/JAPhA.2013.11176","article-title":"Development, implementation, and evaluation of a pharmacist-conducted screening program for depression","volume":"53","author":"Rosser","year":"2013","journal-title":"J.\u00a0Am. Pharm. Assoc. (2003)"},{"issue":"11","key":"10.1016\/j.japh.2024.102180_bib15","first-page":"13","article-title":"The role of the community pharmacist in mental health","volume":"43","author":"Kyle","year":"2018","journal-title":"US Pharm"},{"issue":"3","key":"10.1016\/j.japh.2024.102180_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1331\/154434503321831111","article-title":"Unmet needs in the medication use process: perceptions of physicians, pharmacists, and patients","volume":"43","author":"Law","year":"2003","journal-title":"J.\u00a0Am. Pharm. Assoc. (2003)"},{"issue":"1","key":"10.1016\/j.japh.2024.102180_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sapharm.2006.03.003","article-title":"Pharmacists\u2019 and patients\u2019 roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?","volume":"3","author":"Worley","year":"2007","journal-title":"Res. Social Adm. Pharm"},{"issue":"8","key":"10.1016\/j.japh.2024.102180_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1532-5415.2011.03500.x","article-title":"Beyond the prescription: medication monitoring and adverse drug events in older adults","volume":"59","author":"Steinman","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.japh.2024.102180_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cptl.2016.02.015","article-title":"Mental health first aid training needs of Australian community pharmacists","volume":"8","author":"Kirschbaum","year":"2016","journal-title":"Curr Pharm Teach Learn"},{"issue":"11","key":"10.1016\/j.japh.2024.102180_bib20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00127-018-1553-7","article-title":"Community pharmacists\u2019 experiences and people at risk of suicide in Canada and Australia: a thematic analysis","volume":"53","author":"Murphy","year":"2018","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"5S","key":"10.1016\/j.japh.2024.102180_bib21","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.japh.2020.03.010","article-title":"Patient and prescriber perceptions of depression screening within a community pharmacy setting","volume":"60","author":"Mospan","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T05:44:50Z","timestamp":1730958290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1544319124002000"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102180","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102067","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102180"}}